呼出气一氧化氮作为非小细胞肺癌放疗后放射性肺炎潜在生物标志物的初步研究
该初步研究纳入50例接受高剂量放疗的非小细胞肺癌患者,重复测量呼出气一氧化氮(FeNO),发现发生≥2级放射性肺炎者放疗期间平均FeNO显著高于未发生者,平均FeNO≥14.8 ppb对≥2级放射性肺炎有预测价值。
要点
- 放疗期间平均FeNO在≥2级放射性肺炎患者中显著升高。
- 平均FeNO≥14.8 ppb预测≥2级放射性肺炎特异性71%、阳性预测值78%。
- FeNO可能作为放射性肺炎的潜在生物标志物。
核心结论
- 非小细胞肺癌高剂量放疗后有症状放射性肺炎患者的平均FeNO显著高于无放射性肺炎患者,FeNO可能作为放射性肺炎的潜在生物标志物。
研究设计与样本
- 初步研究纳入50例接受高剂量放疗的非小细胞肺癌患者,基线、放疗期间每周及放疗后1个月和每3个月测量FeNO,随访1年。
主要发现
- 42例完成高剂量放疗和每周FeNO测量,24例(57%)诊断为≥2级放射性肺炎。
- 有放射性肺炎者平均FeNO为15.0±7.1 ppb(95%CI:12.0-18.0),无放射性肺炎者为10.3±3.4 ppb(95%CI:8.6-11.9),组间差异显著(p=0.0169,95%CI:2.3-2.6)。
- 留一交叉验证得出的平均FeNO≥14.8 ppb预测≥2级放射性肺炎的特异性为71%,阳性预测值为78%。
关键数值与推荐
- 放射性肺炎按CTCAE分级,≥2级定义为有症状。
- 平均FeNO(visit 0-6)取基线和放疗期间每周测量的算术平均值。
- 平均FeNO≥14.8 ppb为留一交叉验证 cut-off 值,预测≥2级放射性肺炎特异性71%、阳性预测值78%。
临床怎么用
- 对接受高剂量放疗的非小细胞肺癌患者,可考虑重复测量FeNO以辅助识别放射性肺炎高风险者。
局限性
- 本研究为初步研究,样本量有限,FeNO作为生物标志物的价值需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The aim of the study was to investigate repetitive fractional exhaled nitric oxide (FeNO) measurements during high-dose radiation therapy (HDRT) and to evaluate the use of FeNO to predict symptomatic radiation pneumonitis (RP) in patients being treated for non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: A total of 50 patients with NSCLC referred for HDRT were enrolled. FeNO was measured at baseline, weekly during HDRT, one month- and every third month after HDRT for a one-year follow-up period. The mean FeNO(visit 0-6) was calculated using the arithmetic mean of the baseline and weekly measurements during HDRT. Patients with grade ≥ 2 of RP according to the Common Terminology Criteria for Adverse Events (CTCAE) were considered symptomatic. RESULTS: A total of 42 patients completed HDRT and weekly FeNO measurements. Grade ≥ 2 of RP was diagnosed in 24 (57%) patients. The mean FeNO(visit 0-6) ± standard deviation in patients with and without RP was 15.0 ± 7.1 ppb (95%CI: 12.0-18.0) and 10.3 ± 3.4 ppb (95%CI: 8.6-11.9) respectively with significant differences between the groups (p = 0.0169, 95%CI: 2.3-2.6). The leave-one-out cross-validated cut-off value of the mean FeNO(visit 0-6) ≥ 14.8 ppb was predictive of grade ≥ 2 RP with a specificity of 71% and a positive predictive value of 78%. CONCLUSIONS: The mean FeNO(visit 0-6) in patients with symptomatic RP after HDRT for NSCLC was significantly higher than in patients without RP and may serve as a potential biomarker for RP.
引用
- Szejniuk WM, Nielsen MS, Brønnum D, et al. Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer: A pilot study. Clin Transl Radiat Oncol. 2019. PMID: 31650045. doi:10.1016/j.ctro.2019.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。